Zika Vaccine Development

Zika vaccine development has focused on preventing the Zika virus, which is primarily spread by mosquitoes and can cause severe birth defects. Researchers have explored various vaccine types, including live attenuated, inactivated, and messenger RNA (mRNA) vaccines. Early trials showed promise, demonstrating safety and the ability to generate an immune response. Efforts intensified after the 2015 outbreak, leading to several candidates undergoing clinical trials. While no Zika vaccine is yet widely available, ongoing research aims to ensure efficacy and safety for global populations, especially pregnant women and those living in affected areas.